Pharmaceutical

Trump revives plan for IRP use in US via MFN executive order

US President Donald Trump has resurrected a drug pricing plan that equates to International Reference Pricing.

May 18, 2025 - 06:00
Trump revives plan for IRP use in US via MFN executive order
US President Donald Trump has resurrected a drug pricing plan that equates to International Reference Pricing.
Read the original article

Tags:

Previous Article

Pharma’s AI prospects get nudged into the future with EU’s AI act 

Next Article

Influence of high-energy milling on the biological activity of microbial particles.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves BMS’ Opdivo for urothelial carcinoma

FDA approves BMS’ Opdivo for urothelial carcinoma

Mar 9, 2024

Keytruda remains Merck & Co’s biggest 2023 success story as patent expiry looms

Keytruda remains Merck & Co’s biggest 2023 success stor...

Feb 2, 2024

Incyte stock hit 11% despite paediatric dermatology trials hitting target

Incyte stock hit 11% despite paediatric dermatology tri...

Mar 19, 2025